Diego Bagnasco Selected Research

Diego Bagnasco Research Topics

Disease

57	Asthma (Bronchial Asthma) 04/2024 - 01/2016
8	Inflammation (Inflammations) 02/2024 - 01/2016
7	Rhinosinusitis 02/2024 - 01/2019
7	Hypersensitivity (Allergy) 12/2019 - 11/2016
4	Eosinophilia 02/2024 - 04/2016
4	Nasal Polyps (Nasal Polyp) 02/2024 - 05/2022
4	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 04/2016
3	Allergic Rhinitis 10/2021 - 11/2016
2	Eosinophilic Esophagitis 09/2023 - 12/2022
2	COVID-19 01/2023 - 07/2022
2	Atopic Dermatitis (Atopic Eczema) 05/2022 - 11/2016
1	Chronic Urticaria 12/2022
1	Neoplasms (Cancer) 12/2022
1	Respiratory Insufficiency (Respiratory Failure) 07/2022
1	Cerebrospinal Fluid Leak 01/2022
1	Respiratory Tract Infections (Respiratory Tract Infection) 10/2020
1	Infections 10/2020
1	Bronchiectasis 01/2020
1	Gastroesophageal Reflux (GERD) 01/2020
1	Bites and Stings (Sting) 12/2019
1	Pneumonia (Pneumonitis) 11/2019
1	Oral Candidiasis (Thrush) 11/2019
1	Fever (Fevers) 01/2019
1	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 01/2019
1	Rhinitis 01/2019
1	Food Hypersensitivity (Food Allergy) 01/2018
1	Idiopathic Pulmonary Fibrosis 01/2017
1	Lung Diseases (Lung Disease) 01/2017
1	Dust Mite Allergy 11/2016
1	Sleep Apnea Syndromes (Sleep Apnea) 08/2016
1	Immune System Diseases (Immune Disorders) 02/2016

Drug/Important Bio-Agent (IBA)

14	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2024 - 01/2017
13	mepolizumabIBA 12/2023 - 04/2016
8	benralizumabIBA 02/2023 - 04/2016
8	Interleukin-5 (Interleukin 5)IBA 10/2020 - 04/2016
6	Immunoglobulin E (IgE)IBA 01/2023 - 01/2018
6	Monoclonal AntibodiesIBA 10/2021 - 04/2016
5	SteroidsIBA 02/2024 - 01/2019
4	dupilumabIBA 02/2024 - 01/2016
4	Omalizumab (Xolair)FDA Link 12/2022 - 01/2017
4	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2016
4	Interleukin-13IBA 10/2020 - 01/2016
4	CytokinesIBA 10/2020 - 08/2016
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2023 - 01/2020
3	reslizumabIBA 01/2019 - 04/2016
3	AllergensIBA 01/2018 - 01/2017
2	AntibodiesIBA 12/2022 - 01/2020
2	Interleukin-5 Receptors (Interleukin 5 Receptor)IBA 12/2022 - 01/2018
2	Interleukin-4 (Interleukin 4)IBA 10/2020 - 01/2016
2	Arthropod VenomsIBA 01/2018 - 11/2016
2	TabletsIBA 01/2017 - 11/2016
2	InterleukinsIBA 04/2016 - 01/2016
1	salicylhydroxamic acid (SHAM)IBA 01/2023
1	propanoldiaminetetracetic acidIBA 01/2023
1	Enterotoxins (Enterotoxin)IBA 01/2023
1	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 12/2022
1	Oxygen (Dioxygen)IBA 07/2022
1	GoldIBA 01/2022
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2022
1	Bacterial LysatesIBA 10/2020
1	Interleukin-33IBA 10/2020
1	ChemokinesIBA 10/2020
1	Thymic Stromal LymphopoietinIBA 10/2020
1	Chemokine CCL24IBA 10/2020
1	Tyrosine (L-Tyrosine)FDA Link 12/2019
1	Budesonide (Pulmicort)FDA LinkGeneric 11/2019
1	Formoterol Fumarate (Oxis)FDA Link 11/2019
1	Methotrexate (Mexate)FDA LinkGeneric 01/2019
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2019
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2019
1	Environmental Pollutants (Pollutants, Environmental)IBA 01/2018
1	Muscarinic AntagonistsIBA 06/2017
1	GSK573719IBA 06/2017
1	AerosolsIBA 11/2016
1	VaccinesIBA 11/2016
1	anti-IgE antibodiesIBA 08/2016
1	Biosimilar PharmaceuticalsIBA 02/2016

Therapy/Procedure

14	Therapeutics 04/2024 - 01/2016
9	Precision Medicine 09/2023 - 01/2016
4	Biological Therapy 01/2022 - 02/2016
3	Immunotherapy 01/2019 - 01/2016
1	Transcranial Direct Current Stimulation 01/2023
1	Length of Stay 07/2022
1	Artificial Respiration (Mechanical Ventilation) 07/2022
1	Immunomodulation 10/2020
1	Bronchial Thermoplasty 01/2020
1	Drug Therapy (Chemotherapy) 01/2020
1	Self Administration (Administration, Self) 01/2020
1	Continuous Positive Airway Pressure 08/2016